NCT03236922

Brief Summary

It is clear from multiple accounts in the literature that patients with a vesico-vaginal fistula (VVF) involving the bladder neck and/or proximal urethra have a high likelihood of residual incontinence. Performing subsequent surgeries after the initial VVF repair risks additional complications. Therefore, placement of an autologous sling at the time of initial VVF repair would not only assist in covering the fistula, but would also imitate the physiologic support that would theoretically improve urethral function. A rectus fascia sling would most naturally provide this support and warrants testing against the success of the PC sling. Using the Goh scoring criteria, Goh class 3 and 4 VVF's are the type most involving the urethra. Therefore, this group of patients is the target population for this study. As there is currently no standard of care for repairing large urethral defects, this procedural technique combined with otherwise standardized fistula repair would not introduce any foreseeable harm to patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 21, 2016

Completed
12 months until next milestone

First Posted

Study publicly available on registry

August 2, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2019

Completed
Last Updated

August 2, 2017

Status Verified

July 1, 2017

Enrollment Period

2.2 years

First QC Date

August 21, 2016

Last Update Submit

July 29, 2017

Conditions

Keywords

obstetric fistula, anti-incontinence techniques

Outcome Measures

Primary Outcomes (1)

  • Long-term Continence Status

    Residual stress incontinence is commonly experienced by this patient population, therefore a dye test to ensure the fistula is still closed and a cough test to determine any incontinence will be performed.

    Six months after surgery

Secondary Outcomes (1)

  • Vesico-vaginal fistula repaired

    One month after surgery

Study Arms (2)

Pubococcygeus Sling

ACTIVE COMPARATOR

This is one anti-incontinence technique commonly used at the time of fistula surgery.

Procedure: Pubococcygeus sling

Rectus Fascia Sling

ACTIVE COMPARATOR

This is another anti-incontinence technique used at the time of fistula surgery, however, less commonly than the pubococcygeus.

Procedure: Rectus fascia sling

Interventions

The pubococcygeus muscles is dissected from the vaginal side walls and approximated at the midline just below the urethra.

Also known as: pubococcygeal sling, pubococcygeus graft
Pubococcygeus Sling

Rectus fascia is dissected out cephalad to the pubic symphysis and tunneled beneath the urethra.

Also known as: rectus fascia graft
Rectus Fascia Sling

Eligibility Criteria

Age18 Years - 90 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women with vesico-vaginal fistulas classified as Goh 3 or 4 at the time of surgery
  • Patients who have consented for an autologous sling
  • Patients who have not previously undergone repair attempt

You may not qualify if:

  • Patients who require an abdominal approach to the VVF repair
  • Patients found at surgery not to have a Goh 3 or 4 class VVF
  • Patients requiring a complete urethral reconstruction
  • Patients who have undergone previous attempt at repair
  • Patients who require an alternative tissue grafting other than the rectus fascia or pubbococcygeus decided by the surgeon at the time of surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fistula Care Center

Lilongwe, Malawi

Location

Related Publications (5)

  • Ascher-Walsh CJ, Capes TL, Lo Y, Idrissa A, Wilkinson J, Echols K, Crawford B, Genadry R. Sling procedures after repair of obstetric vesicovaginal fistula in Niamey, Niger. Int Urogynecol J. 2010 Nov;21(11):1385-90. doi: 10.1007/s00192-010-1202-5. Epub 2010 Jun 17.

    PMID: 20556597BACKGROUND
  • Browning A. Risk factors for developing residual urinary incontinence after obstetric fistula repair. BJOG. 2006 Apr;113(4):482-5. doi: 10.1111/j.1471-0528.2006.00875.x. Epub 2006 Feb 20.

  • Browning A. Prevention of residual urinary incontinence following successful repair of obstetric vesico-vaginal fistula using a fibro-muscular sling. BJOG. 2004 Apr;111(4):357-61. doi: 10.1111/j.1471-0528.2004.00080.x.

  • Carey MP, Goh JT, Fynes MM, Murray CJ. Stress urinary incontinence after delayed primary closure of genitourinary fistula: a technique for surgical management. Am J Obstet Gynecol. 2002 May;186(5):948-53. doi: 10.1067/mob.2002.122247.

  • Pope R, Browning A, Chipungu E, George JOM, Tamimu M, Wilkinson J. Prophylactic Autologous Slings at the Time of Obstetric Fistula Repair: A Randomized Clinical Trial. Female Pelvic Med Reconstr Surg. 2021 Feb 1;27(2):78-84. doi: 10.1097/SPV.0000000000000745.

MeSH Terms

Conditions

Vesicovaginal Fistula

Condition Hierarchy (Ancestors)

Vaginal FistulaVaginal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrinary Bladder FistulaUrinary FistulaUrogenital AbnormalitiesUrinary Bladder DiseasesUrologic DiseasesGenital DiseasesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Rachel Pope, MD, MPH

    Baylor College of Medicine

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Obstetrics and Gynecology

Study Record Dates

First Submitted

August 21, 2016

First Posted

August 2, 2017

Study Start

June 1, 2016

Primary Completion

August 1, 2018

Study Completion

August 1, 2019

Last Updated

August 2, 2017

Record last verified: 2017-07

Data Sharing

IPD Sharing
Will share

No.

Locations